Highly efficient gene transfer to solid tumors in vivo by tumor-selective replicating retrovirus vectors

International Journal of Molecular Medicine

Volumn 25, Issue 5, 2010, Pages 769-775

  Lu, Yin Che ^a   Lou, Yi Ping ^b   Wang, Yu Wen ^b   Tai, Chien Kuo ^b  

^a CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^b NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

Author keywords

Breast cancer; Cytosine deaminase; Replicating retrovirus; Suicide gene; Thymidine kinase

Indexed keywords

CYTOSINE DEAMINASE; FLUCYTOSINE; GANCICLOVIR; RETROVIRUS VECTOR; THYMIDINE KINASE;

ARTICLE; BREAST CANCER; CANCER GENE THERAPY; CANCER INHIBITION; CELL KILLING; CELL STRAIN MDA MB 435; CONTROLLED STUDY; CYTOTOXICITY; GENE TRANSFER; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LABELING INDEX; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; SUICIDE GENE THERAPY; THERAPY EFFECT; TRANSGENE; TUMOR GENE; TUMOR GROWTH; TUMOR XENOGRAFT; VIRAL GENE DELIVERY SYSTEM; VIRUS REPLICATION; YEAST;

ANIMALS; ANTIMETABOLITES; ANTIVIRAL AGENTS; BREAST NEOPLASMS; CELL LINE; CYTOSINE DEAMINASE; FEMALE; FLUCYTOSINE; GANCICLOVIR; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS; RETROVIRIDAE; THYMIDINE KINASE;

EID: 77951739934     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000403     Document Type: Article

References (26)

1. Thomas CE, Ehrhardt A and Kay MA: Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 4: 346-358, 2003. (Pubitemid 36538359)
2. Lewis PF and Emerman M: Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J Virol 68: 510-516, 1994. (Pubitemid 24974657)
3. Miller DG, Adam MA and Miller AD: Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10: 4239-4242, 1990. (Pubitemid 20227308)
4. Varmus HE, Padgett T, Heasley S, Simon G and Bishop JM: Cellular functions are required for the synthesis and integration of avian sarcoma virus-specific DNA. Cell 11: 307-319, 1977. (Pubitemid 8150692)
5. Grote D, Russell SJ, Cornu TI, Cattaneo R, Vile R, Poland GA and Fielding AK: Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice. Blood 97: 3746-3754, 2001.
6. Csatary LK, Moss RW, Beuth J, Torocsik B, Szeberenyi J and Bakacs T: Beneficial treatment of patients with advanced cancer using a newcastle disease virus vaccine (mth-68/h). Anticancer Res 19: 635-638, 1999. (Pubitemid 29168307)
7. Gomella LG, Mastrangelo MJ, McCue PA, Maguire HC, Mulholland SG and Lattime EC: Phase I study of intravesical vaccinia virus as a vector for gene therapy of bladder cancer. J Urol 166: 1291-1295, 2001.
8. Fukazawa T, Matsuoka J, Yamatsuji T, Maeda Y, Durbin ML and Naomoto Y: Adenovirus-mediated cancer gene therapy and virotherapy (Review). Int J Mol Med 25: 3-10, 2010.
9. Andreadis ST, Roth CM, Le Doux JM, Morgan JR and Yarmush ML: Large-scale processing of recombinant retroviruses for gene therapy. Biotechnol Prog 15: 1-11, 1999. (Pubitemid 29087582)
10. Rainov NG: A phase iii clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum Gene Ther 11: 2389-2401, 2000.
11. Gordon EM and Hall FL: The 'timely' development of Rexin-G: First targeted injectable gene vector (Review). Int J Oncol 35: 229-238, 2009.
12. Logg CR, Logg A, Matusik RJ, Bochner BH and Kasahara N: Tissue-specific transcriptional targeting of a replication-competent retroviral vector. J Virol 76: 12783-12791, 2002. (Pubitemid 35386962)
13. Tai CK, Wang WJ, Chen TC and Kasahara N: Single-shot, multicycle suicide gene therapy by replication-competent retrovirus vectors achieves long-term survival benefit in experimental glioma. Mol Ther 12: 842-851, 2005.
14. Tai CK and Kasahara N: Replication-competent retrovirus vectors for cancer gene therapy. Front Biosci 13: 3083-3095, 2008. (Pubitemid 351589220)
15. Nakamura H, Mullen JT, Chandrasekhar S, Pawlik TM, Yoon SS and Tanabe KK: Multimodality therapy with a replicationconditional herpes simplex virus 1 mutant that expresses yeast cytosine deaminase for intratumoral conversion of 5-fluorocytosine to 5-fluorouracil. Cancer Res 61: 5447-5452, 2001. (Pubitemid 32694925)
16. Beltinger C, Fulda S, Kammertoens T, Meyer E, Uckert W and Debatin KM: Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases. Proc Natl Acad Sci USA 96: 8699-8704, 1999. (Pubitemid 29354854)
17. Freeman SM: Suicide gene therapy. Adv Exp Med Biol 465: 411-422, 2000.
18. Mesnil M and Yamasaki H: Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: Role of gap-junctional intercellular communication. Cancer Res 60: 3989-3999, 2000. (Pubitemid 30636571)
19. Pan J, Zhong C, Chang Z and Roy-Burman P: A potential therapeutic strategy to combat leukemia virus infection. Cancer Biol Ther 2: 92-99, 2003.
20. Logg CR, Baranick BT, Lemp NA and Kasahara N: Adaptive evolution of a tagged chimeric gammaretrovirus: Identification of novel cis-acting elements that modulate splicing. J Mol Biol 369: 1214-1229, 2007.
21. Pear WS, Nolan GP, Scott ML and Baltimore D: Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 90: 8392-8396, 1993.
22. Solly SK, Trajcevski S, Frisen C, Holzer GW, Nelson E, Clerc B, Abordo-Adesida E, Castro M, Lowenstein P and Klatzmann D: Replicative retroviral vectors for cancer gene therapy. Cancer Gene Ther 10: 30-39, 2003. (Pubitemid 36222074)
23. Overbaugh J, Miller AD and Eiden MV: Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins. Microbiol Mol Biol Rev 65: 371-389, 2001. (Pubitemid 32881711)
24. Metzl C, Mischek D, Salmons B, Gunzburg WH, Renner M and Portsmouth D: Tissue- and tumor-specific targeting of murine leukemia virus-based replication-competent retroviral vectors. J Virol 80: 7070-7078, 2006. (Pubitemid 44025204)
25. Tai CK, Logg CR, Park JM, Anderson WF, Press MF and Kasahara N: Antibody-mediated targeting of replication-competent retroviral vectors. Hum Gene Ther 14: 789-802, 2003.
26. Soifer H, Higo C, Logg CR, Jih LJ, Shichinohe T, Harboe-Schmidt E, Mitani K and Kasahara N: A novel, helper-dependent, adenovirus-retrovirus hybrid vector: Stable transduction by a two-stage mechanism. Mol Ther 5: 599-608, 2002. (Pubitemid 34546090)